Bibliographic Details
| Title: |
Phenotypic and Genotypic Characterization of Hereditary Angioedema in Saudi Arabia. |
| Authors: |
Sheikh, Farrukh, Alajlan, Huda, Albanyan, Maram, Alruwaili, Hibah, Alawami, Fatimah, Sumayli, Safia, Al Gazlan, Sulaiman, Abu Awwad, Sawsan, Al-Dhekri, Hasan, Al-Saud, Bandar, Arnaout, Rand, Alrayes, Hassan, Sayes, Najla, Al-Hamed, Mohamed H., Al-Mousa, Hamoud, AlShareef, Saad, Alazami, Anas M. |
| Source: |
Journal of Clinical Immunology; Feb2023, Vol. 43 Issue 2, p479-484, 6p |
| Subject Terms: |
ANGIONEUROTIC edema, GENOTYPES, COMPLEMENT inhibition, PHENOTYPES, GASTROINTESTINAL system |
| Geographic Terms: |
SAUDI Arabia |
| Abstract: |
Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disorder affecting roughly 1:50,000 individuals. It is commonly characterized by swelling of the larynx, gastrointestinal tract, extremities, and skin. There is growing genetic heterogeneity associated with this disease but more than 95% of mutations are found in SERPING1, the gene which encodes complement 1 inhibitor (C1-INH). HAE cohorts from several populations have been published but no large scale study has been reported from the Arab world to date. Here we document the clinical and genetic findings of HAE patients from a single Saudi institution, which is a major referral center at the national level. A total of 51 patients across 17 unrelated families were recruited including two large multi-generational families, of which one contained an in-frame exonic deletion that was resolved through MLPA. Two cases were negative for all the genes we tested (including F12, PLG, ANGPT1, MYOF, KNG1, and HS3ST6). The predominant HAE subtype in our cohort was type I, at 76%. We were able to uncover a mutation in 49 patients (96%). No type III (normal C1-INH) patients were encountered in the clinic, suggesting that this subtype does not play a major role in HAE pathogenesis in Saudi Arabia. Additionally, the existence of four patients with consistently normal complement 4 (C4) levels alongside abnormal C1-INH profiles highlights the utility of dual screening for both proteins in suspected patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Immunology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
